Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåíåòèêà

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 28.01.2014, 08:45
Belfry Belfry âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2014
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 12
Belfry *
ìóòàöèè ãåíîâ MTRR G/G MTHFR C/T

Äîáðûé Äåíü! Áûëà áåðåìåííîñòü äâîéíåé ðàçíîÿéöåâîé, îáà ðåáåíî÷êà ñ ñåðüåçíûìè ïàòîëîãèÿìè (ñèíäðîì äàóíà ó ìàëü÷èêà, ñèíäðîì ýäâàðäñà ó äåâî÷êè). Ïðåðûâàíèå ïî ìåä. ïîêàçàòåëÿì. Ñäàëè àíàëèçû íà êàðèîòèï è ñèíäðîì íåðàñõîæäåíèÿ õðîìàñîì. Ó ìåíÿ è ìóæà êàðèîòèï íîðìàëüíûé, íî ó ìåíÿ îáíàðóæèëè ìóòàöèè ãåíîâ MTRR G/G MTHFR C/T.

ß òàê ïîíèìàþ, èìåííî ýòè ìóòàöèè ïîâëèÿëè íà íåðàñõîæäåíèå õðîìàñîì, ÷òî ïðèâåëî ê òàêèì ñåðüåçíûì ïàòîëîãèÿì.
×òî ìíå äàëüøå äåëàòü, ê êàêîìó âðà÷ó èäòè. Ãåíåòèê ïðîïèñàë ôîëèåâóþ è B6. Ìîæåò, ìíå åùå êàêèå àíàëèçû ñäàòü èëè ñäàâàòü âî âðåìÿ ïëàíèðîâàíèÿ è íóæíî ëè îáðàòèòüñÿ ê ãåìàòîëîãó? Íàñêîëüêî ìîè ìóòàöèè ñåðüåçíû?
Ãåíåòèê ñêàçàë, ÷òî ðèñê ïîâòîðåíèÿ âûñîê.
Ïîìîãèòå, ïîæàëóéñòà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 29.01.2014, 19:38
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,313
Ïîáëàãîäàðèëè 33,197 ðàç(à) çà 31,547 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âû íåïðàâèëüíî ïîíèìàåòå: äàííûå ìóòàöèè âñòðå÷àþòñÿ ó êàæäîé 3-4-îé æåíùèíû, íî ïðîáëåìíûå áåðåìåííîñòè áûâàþò íå ÷àùå 1-2 %. Âîçðàñò ñóïðóãîâ âëèÿåò íà ðèñê ïîÿâëåíèÿ ñèíäðîìà Äàóíà ó äåòåé, ïîñëå îïðåä. âîçðàñòà ðåêîìåíäóåòñÿ ñêðèíèðîâàíèå...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 30.01.2014, 20:40
Belfry Belfry âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2014
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 12
Belfry *
Ýòî ãåíåòèê íàì ñêàçàë,÷òî ïðè÷èíà â íåðàñõîæäåíèè õðîìîñîì èç-çà ýòèõ ãåíîâ. Ñïðàøèâàëè åãî, ñâÿçàíî ñ âîçðàñòîì-îòâåò íåò!  Ñå÷åíîâî áûëî îáñëåäîâàíèå. Âîçðàñò ìíå 34, ìóæó 44. Ñòðàííî, ÷òî ðàçíîÿéöåâûå ìàëûøè è îáà ñ ïðîáëåìàìè ñåðüåçíûìè. Êàê òàê ìîæíî ïîïàñòü ñ ñèíäðîìîì Ýäâàðäñà â 1 íà 7000 è Äàóíà 1 íà 700. Ïûòàþñü íàéòè íàó÷íîå îáúÿñíåíèå òàêîé "âåçó÷åñòè". ×òî äåéñòâèëüíî ïîâëèÿëî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 31.01.2014, 00:51
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,313
Ïîáëàãîäàðèëè 33,197 ðàç(à) çà 31,547 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ó æåíùèíû â 35 ëåò øàíñû ïîÿâëåíèÿ ðåáåíêà ñ ñ-ìîì Äàóíà 1:365; ñîãëàñíî íåäàâíåìó ìåòà-àíàëèçó ðèñê äàííîãî ñèíäðîìà ó íîñèòåëåé MTRR G/G èëè MTHFR C/T íå ïðåâûøàåò +10-15% ó åâðîïåéöåâ è ñ÷èòàåòñÿ íåçíà÷èòåëüíûì; íåãàòèâíîå âëèÿíèå âîçðàñòà îòöà óñèëèâàåòñÿ, êîãäà æåíñêèé âîçðàñò 35 è ñòàðøå. ×òî Âû ìîæåòå ñäåëàòü, ýòî èçìåðÿòü óðîâåíü ãîìîöèñòåèíà è åñëè îí îêàæåòñÿ áîëåå 12-15, òî ñ ïîìîùüþ ôîëèåâîé è äð. âèòàìèíîâ ïðèâåñòè åãî óðîâåíü ê öèôðàì ìåíåå 10. Õîòÿ ýòî è íå ïðåäóïðåäèò 100% ïîÿâëåíèå àíîìàëèé ó ïëîäà, íî ìîæåò ïîìî÷ü ñíèçèòü äàííûé ðèñê.

Êîììåíòàðèè ê ñîîáùåíèþ:
nata-k îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 31.01.2014, 20:01
Belfry Belfry âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2014
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 12
Belfry *
ò.å ó äâîèõ äåòåé ñîâåðøåííî ðàçíûõ è ó îáîèõ ñèíäðîìû, ïðè÷åì ó âòîðîãî ýäâàðäñà
èç-çà âîçðàñòíîãî ðèñêà? íàøè âðà÷è ãîâîðÿò, îáû÷íî òîëüêî îäèí..è, ÷òî òàêèõ ñëó÷àåâ íå âñòðå÷àëè. Ïðîïèñàëè ìíå çà 3 ìåñ äî ïëàíèðîâàíèÿ ïðîïèâàòü ôîëèåâóþ è B6. Âñå âåðíî? Ñïàñèáî Áîëüøîå çà îòâåòû.
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 31.01.2014, 20:08
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,313
Ïîáëàãîäàðèëè 33,197 ðàç(à) çà 31,547 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñòîÿòåëüíî ðåêîìåíäóþ îçíàêîìèòüñÿ ñ äîñòóïíîé àíãëîÿçû÷íîé ëèòåðàòóðîé, äàæå åñëè Âàì íóæåí áóäåò î÷íûé ìåä. ïåðåâîä÷èê, íàïð.

Edwards' syndrome, also known as Trisomy 18... Advanced maternal age is a risk factor for Trisomy 18.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Câîè ðåêîìåíäàöèè ïðèâåë âûøå, ôîëèåâàÿ îáÿçàòåëüíà ïðè ïëàíèðîâàíèè âñåì, Â6 è Â12 òîëüêî â ñëó÷àå âûñîêîãî ãîìîöèñòåèíà.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 31.01.2014, 20:33
Belfry Belfry âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2014
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 12
Belfry *
Ñïàñèáî îãðîìíîå! íàñêîëüêî ñòðåññ ìîã ïîâëèÿòü ? ìû â ìîìåíò äåëåíèÿ êëåòîê
, âèäèìî, ïîïàëè â ñòðàøíåéøèé ïåðåëåò
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 31.01.2014, 20:36
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,313
Ïîáëàãîäàðèëè 33,197 ðàç(à) çà 31,547 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òðóäíî ïðåäñêàçàòü, ÷òî èìåííî áûëî òîãäà ïóñêîâûì ìåõàíèçìîì, Âàì ñëåäóåò äâèãàòüñÿ âïåðåä...
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 31.01.2014, 20:39
Belfry Belfry âíå ôîðóìà Ïîë æåíñêèé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2014
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 12
Belfry *
Åùå ðàç ñïàñèáî Âàì, âñå ïîíÿòíî! ß áóäó ñòàðàòüñÿ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 07.09.2015, 12:11
bizet bizet âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 25.11.2009
Ãîðîä: Íèæíèé Íîâãîðîä
Ñîîáùåíèé: 4
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 2 ðàç(à) çà 2 ñîîáùåíèé
bizet *
Äîáðûé äåíü!
Íåáîëüøàÿ ðåìàðêà: íàëè÷èå ïîëèìîðôèçìà MTRR G/G òðåáóåò êîíòðîëÿ óðîâíÿ öèàíîêîáàëàìèíà (Âèò Â12) áîëüøå, ÷åì äðóãèõ âèòàìèíîâ.
Ôîëèåâàÿ íóæíà âñåì áåðåìåííûì, íî åå ïðèåì â âèäå ìîíîäîáàâêè â âàøåì ñëó÷àå ìîæåò ïðèâåñòè ê äåôèöèòó Â12, ïîýòîìó Âàì ïðèíèìàòü íóæíî ôîëèåâóþ â ñî÷åòàíèè ñ Â12 (ëèáî â ñîñòàâå êîìïëåêñíûõ ïîëèâèòàìèíîâ äëÿ áåðåìåííûõ, ãäå åñòü íîðìàëüíûå ïðîôèëàêòè÷åñêèå äîçû îáîèõ).
È åùå îäíà ðåìàðêà: íîðìàòèâû ïî ãîìîöèñòåèíó ïîñòîÿííî ïåðåñìàòðèâàþòñÿ, ïî îäíèì èç ïîñëåäíèõ ðåêîìåíäàöèé ÂÎÇ îïòèìàëüíûì ñ÷èòàåòñÿ óðîâåíü íèæå 8 ìêìîëü/ë (äëÿ âçðîñëîãî ÷åëîâåêà).
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 07.09.2015, 20:52
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,313
Ïîáëàãîäàðèëè 33,197 ðàç(à) çà 31,547 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé êîëëåãà,

Âû ïîñòóëèðóåòå äîñòàòî÷íî äèñêóòàáåëüíûå ìîìåíòû - íåò íè îäíîãî ïîêàçàíèÿ ê êëèíè÷åñêîìó îïðåäåëåíèþ ãåíîòèïà MTRR, êîòîðûé òî ëè âëèÿåò íà óðîâåíü ãîìîöèñòåèíà/âèòàìèíîâ, òî ëè íåò:

MTRR
The A66G polymorphism in the MTRR gene results in the substitution of isoleucine with methionine at codon 22 (5). In two studies, subjects homozygous for the common allele (AA) had elevated homocysteine levels compared with those who had other genotypes (38, 39); in a third study, genotype was not a significant predictor of homocysteine level (40). No associations were found between genotype and serum folate, vitamin B6, or vitamin B12 in the single known study (38).

è èìååòñÿ ó êàæäîãî òðåòüåãî-ïÿòîãî èíäèâèäà ïëàíåòû Çåìëÿ:

MTRR
The lowest reported prevalence of GG homozygotes was 8–10 percent in Japanese in Hawaii and in Hawaiians (5, 14, 38–40, 54, 83–85; Web table 2). Among 558 subjects in Northern Ireland, 12 percent (95 percent CI: 9.1, 14.6) were GG homozygotes, but this series was not in Hardy-Weinberg equilibrium. In most of the remaining series, the frequency was 19–29 percent. Among 97 African Americans and 96 Hispanics, the frequencies were 42 percent (95 percent CI: 32.3, 52.7) and 50 percent (95 percent CI: 39.6, 60.4), respectively.

âñå îòñþäà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Óðîâåíü ãîìîöèñòåèíà çàâèñèò îò ïîëà è âîçðàñòà è íèêàê íå ìîæåò ñ÷èòàòüñÿ îïòèìàëüíûì "óðîâåíü íèæå 8 ìêìîëü/ë (äëÿ âçðîñëîãî ÷åëîâåêà)" íè ñ ïîçèöèè ÂÎÇ, íè êàêèõ ëèáî äðóãèõ (åñëè êîíå÷íî íå ñ÷èòàòü, ÷òî îïòèìàëüíûé âçðîñëûé - ýòî ìîëîäàÿ äåâóøêà/æåíøèíà äåòîðîäíîãî âîçðàñòà), íî åñëè ó Âàñ èìåþòñÿ äîêóìåíòàëüíûå ññûëêè îò íåäàâíèõ ðåêîìåíäàöèé ÂÎÇ, íî ìîæåì îáñóäèòü...

Êîììåíòàðèè ê ñîîáùåíèþ:
nata-k îäîáðèë(à):
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 23:13.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.